Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction. (July 2016) - Hendriks, D.; He, Y.; Koopmans, I.; Wiersma, V.; Van Ginkel, R.; Samplonius, D.; Helfrich, W.; Bremer, E.